Aging
Navigate
Research Paper|Volume 7, Issue 1|pp 38—51

Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination

Juilee Thakar1,8,9, Subhasis Mohanty3, A. Phillip West4, Samit R. Joshi3, Ikuyo Ueda3, Jean Wilson3, Hailong Meng1, Tamara P. Blevins5, Sui Tsang6, Mark Trentalange6, Barbara Siconolfi3, Koonam Park7, Thomas M. Gill6, Robert B. Belshe5, Susan M. Kaech7, Gerald S. Shadel4, Steven H. Kleinstein1,2,7, Albert C. Shaw3
  • 1Department of Pathology, Yale School of Medicine, New Haven CT 06520, USA
  • 2Interdepartmental Program in Computational Biology and Bioinformatics, Yale School of Medicine, New Haven, CT 06520, USA
  • 3Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520, USA
  • 4Department of Pathology and Genetics, Yale School of Medicine, New Haven CT 06520, USA
  • 5Center for Vaccine Development, Saint Louis University, St. Louis, MO 63104, USA
  • 6Department of Internal Medicine, Yale School of Medicine, New Haven, CT 0652, USA
  • 7Department of Immunobiology, Yale School of Medicine, New Haven, CT 06520, USA
  • 8Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA
  • 9Department of Biostatistics and Computational Biology, University of Rochester, Rochester NY 14642, USA

* * Equal contribution

# Co-senior authors
Received: November 25, 2014Accepted: January 12, 2015Published: January 14, 2015

Copyright: © 2015 Thakar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

To elucidate gene expression pathways underlying age-associated impairment in influenza vaccine response, we screened young (age 21-30) and older (age ≥65) adults receiving influenza vaccine in two consecutive seasons and identified those with strong or absent response to vaccine, including a subset of older adults meeting criteria for frailty. PBMCs obtained prior to vaccination (Day 0) and at day 2 or 4, day 7 and day 28 post-vaccine were subjected to gene expression microarray analysis. We defined a response signature and also detected induction of a type I interferon response at day 2 and a plasma cell signature at day 7 post-vaccine in young responders. The response signature was dysregulated in older adults, with the plasma cell signature induced at day 2, and was never induced in frail subjects (who were all non-responders). We also identified a mitochondrial signature in young vaccine responders containing genes mediating mitochondrial biogenesis and oxidative phosphorylation that was consistent in two different vaccine seasons and verified by analyses of mitochondrial content and protein expression. These results represent the first genome-wide transcriptional profiling analysis of age-associated dynamics following influenza vaccination, and implicate changes in mitochondrial biogenesis and function as a critical factor in human vaccine responsiveness.